STAT+: Are we ready to let AI interpret X-rays all by itself?
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
You\u2019re reading the web edition of STAT\u2019s Health Tech newsletter, our guide to how technology is transforming the life sciences.\u00a0Sign up to get it<\/a>\u00a0delivered in your inbox every Tuesday and Thursday.<\/em><\/p>\n Katie Palmer braved frigid temperatures in Chicago last week to learn about the hot, hot world of using artificial intelligence to analyze medical imaging at the Radiological Society of North America annual meeting. She\u2019s already delivered two brilliant readouts:<\/p>\n Speaking of frigid temperatures, last week I drove 60 terrifying, snowy miles on uncleared Vermont highway to attend a digital health summit at Dartmouth College\u2019s Center for Technology and Behavioral Health. On top of some very interesting perspectives on AI regulation throughout the day, the highlight was the first U.S. presentation of data from an RCT of\u00a0an experimental digital therapeutic, CT-155, that treats negative symptoms of schizophrenia, including lack of motivation and the inability to feel pleasure.<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n\n
Schizophrenia DTx is headed\u00a0to FDA<\/h2>\n